FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156831708> ?p ?o ?g. }

• W2156831708 endingPage "1563" @default.
• W2156831708 startingPage "1557" @default.
• W2156831708 abstract "This retrospective study of the thrombocythemia Italian registry (RIT) documented that 71 (30.6%) out of 232 ET patients experienced 88 cardiovascular adverse events (CV-AEs) during anagrelide treatment (522 pt-y). The rate of CV-AEs was: 24.1% for palpitations, 4.3% for angina, 3.5% for arterial hypertension, 3.0% for congestive heart failure, 1.8% for arrhythmia, 0.9% for AMI, 0.4% for pericardial effusion. CV-AEs led to treatment discontinuation in nine (3.9%) patients, while in the remaining cases they were managed by pharmacological intervention and/or patient life style improvement. CV-AEs had no relationship with patient characteristics (including older age). A significant relationship was found only with a higher anagrelide induction dose. In the absence of any agreed protocol, a cardiovascular instrumental evaluation (CV-IE) was performed in 102 (44%) patients before commencement of anagrelide (with higher rate after the anagrelide/Xagrid EMA approval of 2004), and in 84 (36%) patients during treatment. Patients with and without CV-IEs, who resulted completely balanced for all their characteristics, did not significantly differ in the occurrence of CV-AEs. In conclusion, this study on ET patients treated with anagrelide shows that CV-AEs, equally distributed in younger and older subjects, were mostly mild and easily manageable, allowing safe treatment continuation in the majority of cases. Moreover, routinely performing a CV-IE did not appear to anticipate the occurrence of CV-AEs." @default.
• W2156831708 created "2016-06-24" @default.
• W2156831708 creator A5003619706 @default.
• W2156831708 creator A5004633066 @default.
• W2156831708 creator A5006463286 @default.
• W2156831708 creator A5006810419 @default.
• W2156831708 creator A5008040655 @default.
• W2156831708 creator A5008566093 @default.
• W2156831708 creator A5009340562 @default.
• W2156831708 creator A5012968088 @default.
• W2156831708 creator A5013237232 @default.
• W2156831708 creator A5019087367 @default.
• W2156831708 creator A5023661824 @default.
• W2156831708 creator A5033613825 @default.
• W2156831708 creator A5035335560 @default.
• W2156831708 creator A5037391469 @default.
• W2156831708 creator A5045651843 @default.
• W2156831708 creator A5046772202 @default.
• W2156831708 creator A5053851132 @default.
• W2156831708 creator A5056630421 @default.
• W2156831708 creator A5057593886 @default.
• W2156831708 creator A5068835269 @default.
• W2156831708 creator A5071466957 @default.
• W2156831708 creator A5078392742 @default.
• W2156831708 date "2011-12-01" @default.
• W2156831708 modified "2023-09-27" @default.
• W2156831708 title "Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia" @default.
• W2156831708 cites W1963967703 @default.
• W2156831708 cites W1971109164 @default.
• W2156831708 cites W1990387953 @default.
• W2156831708 cites W1992295726 @default.
• W2156831708 cites W1999761512 @default.
• W2156831708 cites W2029070969 @default.
• W2156831708 cites W2034040218 @default.
• W2156831708 cites W2041115302 @default.
• W2156831708 cites W2041220553 @default.
• W2156831708 cites W2046284230 @default.
• W2156831708 cites W2048624723 @default.
• W2156831708 cites W2050914320 @default.
• W2156831708 cites W2069651950 @default.
• W2156831708 cites W2092484653 @default.
• W2156831708 cites W2123643903 @default.
• W2156831708 cites W2129811044 @default.
• W2156831708 cites W2143017944 @default.
• W2156831708 cites W2229971338 @default.
• W2156831708 cites W2334781899 @default.
• W2156831708 cites W2462238653 @default.
• W2156831708 cites W2555269283 @default.
• W2156831708 cites W2979399078 @default.
• W2156831708 doi "https://doi.org/10.1016/j.leukres.2011.06.030" @default.
• W2156831708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21764130" @default.
• W2156831708 hasPublicationYear "2011" @default.
• W2156831708 type Work @default.
• W2156831708 sameAs 2156831708 @default.
• W2156831708 citedByCount "31" @default.
• W2156831708 countsByYear W21568317082012 @default.
• W2156831708 countsByYear W21568317082013 @default.
• W2156831708 countsByYear W21568317082014 @default.
• W2156831708 countsByYear W21568317082015 @default.
• W2156831708 countsByYear W21568317082016 @default.
• W2156831708 countsByYear W21568317082018 @default.
• W2156831708 countsByYear W21568317082020 @default.
• W2156831708 countsByYear W21568317082021 @default.
• W2156831708 countsByYear W21568317082022 @default.
• W2156831708 countsByYear W21568317082023 @default.
• W2156831708 crossrefType "journal-article" @default.
• W2156831708 hasAuthorship W2156831708A5003619706 @default.
• W2156831708 hasAuthorship W2156831708A5004633066 @default.
• W2156831708 hasAuthorship W2156831708A5006463286 @default.
• W2156831708 hasAuthorship W2156831708A5006810419 @default.
• W2156831708 hasAuthorship W2156831708A5008040655 @default.
• W2156831708 hasAuthorship W2156831708A5008566093 @default.
• W2156831708 hasAuthorship W2156831708A5009340562 @default.
• W2156831708 hasAuthorship W2156831708A5012968088 @default.
• W2156831708 hasAuthorship W2156831708A5013237232 @default.
• W2156831708 hasAuthorship W2156831708A5019087367 @default.
• W2156831708 hasAuthorship W2156831708A5023661824 @default.
• W2156831708 hasAuthorship W2156831708A5033613825 @default.
• W2156831708 hasAuthorship W2156831708A5035335560 @default.
• W2156831708 hasAuthorship W2156831708A5037391469 @default.
• W2156831708 hasAuthorship W2156831708A5045651843 @default.
• W2156831708 hasAuthorship W2156831708A5046772202 @default.
• W2156831708 hasAuthorship W2156831708A5053851132 @default.
• W2156831708 hasAuthorship W2156831708A5056630421 @default.
• W2156831708 hasAuthorship W2156831708A5057593886 @default.
• W2156831708 hasAuthorship W2156831708A5068835269 @default.
• W2156831708 hasAuthorship W2156831708A5071466957 @default.
• W2156831708 hasAuthorship W2156831708A5078392742 @default.
• W2156831708 hasConcept C126322002 @default.
• W2156831708 hasConcept C141071460 @default.
• W2156831708 hasConcept C197934379 @default.
• W2156831708 hasConcept C2778715236 @default.
• W2156831708 hasConcept C2778837598 @default.
• W2156831708 hasConcept C2780829020 @default.
• W2156831708 hasConcept C2781057849 @default.
• W2156831708 hasConcept C71924100 @default.
• W2156831708 hasConcept C72563966 @default.
• W2156831708 hasConceptScore W2156831708C126322002 @default.

• next